GSK financial figures

8/7/2019 GSK financial figures

http://slidepdf.com/reader/full/gsk-financial-figures 1/26

PERIOD ENDING Dec-10 Dec-09 Dec-08 Dec-07

Income Statement

44,452,098 45,810,254 35,012,149 45,094,000

Total Revenues 44,452,098 45,810,254 35,012,149 45,094,000

Cost of Sales 9,257,722 9,395,236 7,453,308 8,305,000

11,886,458 11,917,642 9,223,182 10,334,000

Gross Margin 35,194,376 36,415,018 27,558,840 36,789,000

Gross Operating Profit 35,194,376 36,415,018 27,558,840 36,789,000

6,978,127 6,630,601 5,292,366 6,426,000

20,436,504 15,489,705 11,007,433 13,532,000

Operating Income 5,922,875 13,605,167 10,266,990 15,744,000

7,779,743 14,294,711 11,259,039 16,831,000

Depreciation 2,628,736 2,522,406 1,769,873 2,029,000

5,151,007 11,772,305 9,489,166 14,802,000

Interest Income 181,616 113,039 450,016 520,000

* * * 99,000

Other Income, Net 911,211 2,121,921 1,004,989 943,000

* * * -518,000

Special Income/Charges * * * -518,000

All numbers in thousands

Operating Revenue

(Revenue/Sales)

Cost of Sales withDepreciation

Research &Development Expense

Selling, Gen. &Administrative Expense

Operating Income b/f Depreciation (EBITDA)

Operating Income After Depreciation

Earnings from EquityInterest

Income, Restructuringand M&A



6,243,835 14,007,266 10,944,172 15,846,000

Interest Expense 1,301,059 1,264,432 1,212,025 899,000

Pre-tax Income (EBT) 4,942,775 12,742,834 9,732,146 14,947,000

Income Taxes 2,041,615 3,588,211 2,799,304 4,405,000

Minority Interest 342,878 222,850 158,152 191,000

4,942,775 12,742,834 9,573,993 14,946,000

2,558,281 8,931,772 6,774,689 10,350,000

2,558,281 8,931,772 6,774,689 10,350,000

Total Net Income 2,558,281 8,931,772 6,774,689 10,350,000

Normalized Income 2,558,281 8,931,772 6,774,689 10,868,000

2,558,281 8,931,772 6,774,689 10,350,000

Income Statement - Year-to-DateRevenues Year-to-Date 44,452,098 45,810,254 35,012,149 45,094,000

2,558,281 8,931,772 6,774,689 10,350,000

Total Income Avail for Interest Expense (EBIT)

Income before IncomeTaxes

Net Income fromContinuing Operations

Net Income from TotalOperations

Net Income Available for Common

Income Year-to-Date fr.Total Ops.



PERIOD ENDING Dec-10 Dec-09 Dec-08 Dec-07

Balance Sheet - Assets

9,483,177 10,569,236 8,084,482 6,708,000

433,686 641,098 562,161 2,289,000

9,069,843 10,483,649 9,007,519 10,908,000

Other Receivable 87,676 93,661 109,269 115,000

Receivables 9,157,520 10,577,311 9,116,788 11,023,000

Raw Materials 2,295,251 1,861,929 1,620,347 2,194,000

Work in Progress 1,175,807 2,320,549 1,861,889 1,531,000

Finished Goods 2,536,362 2,380,298 2,349,287 2,354,000

Inventories 6,007,421 6,562,777 5,831,524 6,078,000

25,050 22,607 1,233,591 951,000

25,106,856 28,373,031 24,828,548 27,049,000

9,578,682 9,692,369 8,596,322 9,199,000

16,503,577 16,980,218 15,363,823 16,867,000

3,500,806 3,617,278 3,338,461 3,883,000

29,583,065 30,289,866 27,298,606 29,949,000

29,583,065 30,289,866 27,298,606 29,949,000

Cash andEquivalents

MarketableSecurities

AccountsReceivable

Other CurrentAssets

Total CurrentAssets

Land &Improvements

Machinery,Furniture &Equipment

Construction inProgress

Total FixedAssets

Gross FixedAssets (Plant,Prop. & Equip.)



15,421,709 15,152,200 13,384,038 14,424,000

14,161,356 15,137,666 13,914,568 15,525,000

Intangibles 13,358,175 13,214,372 8,438,169 8,846,000

Cost in Excess 5,645,754 5,427,533 3,020,718 2,720,000

4,017,472 3,833,669 3,968,196 4,359,000

3,828,028 3,229,713 2,467,183 3,045,000

41,010,787 40,842,955 31,808,836 34,495,000

Total Assets 66,117,643 69,215,987 56,637,384 61,544,000

Balance Sheet - Liabilities, Stockholders Equity

10,784,236 10,935,809 8,734,346 9,650,000

Short Term Debt 455,605 2,375,454 1,374,491 6,956,000

* * * 520,000

8,791,157 6,257,569 4,293,128 3,411,000

20,030,999 19,568,833 14,401,966 20,536,000

Long Term Debt 23,185,796 23,877,270 21,898,408 13,864,000

* * * 165,000

1,106,918 1,041,582 1,026,555 1,761,000

6,536,612 7,381,509 7,351,228 5,547,000

AccumulatedDepreciation &Depletion

Net Fixed Assets(Net PP&E)

Non-CurrentDeferred IncomeTaxes

Other Non-Current Assets

Total Non-Current Assets

AccountsPayable

DeferredRevenues

Other CurrentLiabilities

Total CurrentLiabilities

Capital LeaseObligations

Deferred IncomeTaxes

Other Non-Current Liabilities



Minority Interest 1,343,332 1,190,149 556,410 609,000

32,172,660 33,490,512 30,832,602 21,946,000

Total Liabilities 52,203,660 53,059,345 45,234,569 42,483,000

13,913,982 16,156,641 11,402,815 19,063,000

Common Par 2,220,099 2,286,637 2,034,419 2,984,000

2,235,756 2,209,123 1,906,459 2,513,000

7,482,268 10,207,509 6,645,292 12,854,000

1,975,857 1,453,371 816,643 713,000

37,099,779 40,033,911 33,301,223 32,927,000

Total Equity 13,913,982 16,156,641 11,402,815 19,063,000

66,117,643 69,215,987 56,637,384 61,546,000

Cash Flow 5,187,017 11,454,178 8,544,563 12,379,000

Working Capital 5,075,856 8,804,198 10,426,581 6,512,000

Free Cash Flow 2,509,746 135,647 2,406,797 393,000

Invested Capital 37,099,779 40,033,911 33,301,223 33,092,000

* = Data not available

Total Non-Current Liabilities

Common StockEquity

Additional Paid InCapital

RetainedEarnings

Other EquityAdjustments

TotalCapitalization

Total Liabilities& Stock Equity



PERIOD ENDING Dec-10 Dec-09 Dec-08

Cash Flow From Operating ActivitiesNet Income (Loss) 2,901,160 9,154,622 6,774,689

Depreciation 1,794,241 1,824,788 1,322,732

834,494 697,618 447,141

2,810,352 3,037,545 3,200,437

1,426,312 -980,218 777,824

372,626 -213,161 -590,916

241,110 1,466,289 -56,072

2,588,028 -516,754 787,888

-280,252 * -232,915

Other Non-Cash Items -2,046,312 -1,808,639 -2,071,801

10,641,762 12,662,091 10,359,006

10,641,762 12,662,091 10,359,006

341,312 652,402 274,610

42,272 95,276 60,385

142,474 * *

-2,559,847 -3,024,626 -2,974,709

Amortization of Intangibles

Operating (Gains)Losses

(Increase) Decrease inReceivables

(Increase) Decrease inInventories

(Increase) Decrease inPayables

(Increase) Decrease inOther Curr Liabs.

(Increase) Decrease inOther Working Capital

Net Cash fromContinuing Operations

Net Cash fromOperating Activities

Sale of Property,Plant, Equipment

Sale of Long TermInvestments

Sale of Short TermInvestments

Purchase of Property,Plant, Equipment



Acquisitions -554,242 -4,508,679 -652,739

-532,322 -295,518 -138,024

195,706 600,726 1,778,499

-2,924,644 -6,480,419 -1,651,977

Issuance of Debt 9,393 3,236,172 7,940,707

123,686 90,431 102,080

Repayment of Debt -2,099,544 -1,285,425 -4,467,097

-25,050 -92,046 -5,355,628

-5,017,926 -4,993,136 -4,324,759

-1,712,827 -1,435,607 -951,792

-8,722,268 -4,479,612 -7,056,489

126,818 -255,147 1,585,841

-878,332 1,446,911 3,236,380

9,970,095 8,836,495 4,631,000

Cash at End of Period 9,091,763 10,283,407 7,867,381

Foreign Sales 41,602,605 42,819,539 20,999,813

Domestic Sales 2,849,493 2,990,714 14,012,335

UQ UQ UQ

Purchase of LongTerm Investments

Other InvestingChanges Net

Net Cash fromInvesting Activities

Issuance of CapitalStock

Repurchase of CapitalStock

Payment of CashDividends

Other FinancingCharges, Net

Net Cash fromFinancing Activities

Effect of ExchangeRate Changes

Net Change in Cash &Cash Equivalents

Cash at Beginning of Period

Auditor's Report (Aud.Name & Aud. Op.)



-2,039,000

*

144,000

-5,973,000

10,154,000

1,058,000

-488,000

-7,446,000

-5,544,000

-1,189,000

-3,456,000

95,000

2,896,000

3,498,000

6,394,000

24,909,000

20,184,000

U



2010/12

79.20%

EBIT Margin 14.00%

EBITDA Margin 17.50%

11.10%

Interest Coverage 4.5

Current Ratio 1.3

Quick Ratio 1

Leverage Ratio 4.8

4.5

1.5

Latest FullContext Quarter Ending Date

Gross ProfitMargin

Pre-Tax ProfitMargin

ReceivablesTurnover

InventoryTurnover



Asset Turnover 0.7

0.7

18.40%

6.90%

Return on Assets 3.90%

1.67

7.64

$5.39

Total Debt/ Equity 1.7

0.62

46.00%

15.70%

Revenue toAssets

ROE from TotalOperations

Return onInvested Capital

Debt/CommonEquity Ratio

Price/Book Ratio(Price/Equity)

Book Value per Share

Long-Term Debtto Total Capital

SG&A as % of Revenue

R&D as % of Revenue

Receivables er



$74.16

244

$1.96

Cash per Share $3.67

$2.01

$0.97

$1.97

20.5

42.3

-20.88

5-Year Averages

Return on Equity 49.60%

Return on Assets 12.90%

Day Sales

Days CGS inInventory

Working Capitalper Share

Cash Flow per Share

Free Cash Flowper Share

Tangible BookValue per Share

Price/Cash FlowRatio

Price/Free CashFlow Ratio

Price/TangibleBook Ratio

Most recent data



Current P/E Ratio 41.2

37.6

16.6

11.3

188%

237%

41.2

A D V E R T I S E M E N T

Price EarningsRatios

P/E Ratio 1Month Ago

P/E Ratio 26Weeks Ago

P/E Ratio 52Weeks Ago

P/E as % of 2Digit MG GroupP/E

P/E as % of 3Digit MG GroupP/E

12 MonthNormalized P/E

Ratio

Most recent data

http://ads.forbes.com/RealMedia/ads/click_lx.ads/forbes.com/markets/finance/compinfo/Ratios/L42/1609154384/Block/OasDefault_v5/CME11874546_hpa_110315/CME11874546.html/676c686a364532706a356b4142514954?http://clk.atdmt.com/DWC/go/306725896/direct/01/1609154384

http://ads.forbes.com/RealMedia/ads/click_lx.ads/forbes.com/markets/finance/compinfo/Ratios/L42/1609154384/Block/OasDefault_v5/CME11874546_hpa_110315/CME11874546.html/676c686a364532706a356b4142514954?http://clk.atdmt.com/DWC/go/306725896/direct/01/1609154384

GSK financial figures

Documents

Transcript of GSK financial figures